685 related articles for article (PubMed ID: 26771973)
1. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
Li W; Zhang S
Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of parathyroid dysfunction in elderly patients on hemodialysis.
Lu JR; Yi Y; Tian J; Xiong CX; Wang XH; Hu J; Chen XF
Blood Purif; 2014; 37(2):119-24. PubMed ID: 24662249
[TBL] [Abstract][Full Text] [Related]
3. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
[TBL] [Abstract][Full Text] [Related]
4. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
[TBL] [Abstract][Full Text] [Related]
5. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
[TBL] [Abstract][Full Text] [Related]
6. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age].
Bednarek-Skublewska A; Baranowicz-Gaszczyk I; Jóźwiak L; Dzik M; Majdan M; Ksiazek A
Pol Arch Med Wewn; 2005 May; 113(5):417-23. PubMed ID: 16479823
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.
Nakai K; Fujii H; Kono K; Goto S; Miura S; Maeda A; Takeda K; Nishi S
Ther Apher Dial; 2013 Feb; 17(1):24-9. PubMed ID: 23379489
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis.
Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients.
Shigematsu T; Shimazaki R; Fukagawa M; Akizawa T;
Clin Exp Nephrol; 2019 Feb; 23(2):258-267. PubMed ID: 30159688
[TBL] [Abstract][Full Text] [Related]
12. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
[TBL] [Abstract][Full Text] [Related]
13. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT;
Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734
[TBL] [Abstract][Full Text] [Related]
14. Histopathological changes of radial artery wall in patients of chronic kidney disease stage 5 undergoing AV fistula formation and their correlation with serum iPTH levels.
Tripathi V; Bansal S; Alok S; Ravi B; Devra AK; Saxena S
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):884-9. PubMed ID: 26354558
[TBL] [Abstract][Full Text] [Related]
15. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.
Ulusoy S; Ozkan G; Guvercin B; Yavuz A
Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947
[TBL] [Abstract][Full Text] [Related]
16. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender.
Indridason OS; Pieper CF; Quarles LD
J Clin Endocrinol Metab; 1998 Nov; 83(11):3860-6. PubMed ID: 9814459
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
18. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
19. Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.
Genctoy G; Arikan S; Gedik O
Int Urol Nephrol; 2015 Feb; 47(2):353-8. PubMed ID: 25537827
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
Douthat WG; Castellano M; Berenguer L; Guzmán MA; de Arteaga J; Chiurchiu CR; Massari PU; Garay G; Capra R; de La Fuente JL
Nefrologia; 2013; 33(5):657-66. PubMed ID: 24089157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
